-
公开(公告)号:WO2022238779A1
公开(公告)日:2022-11-17
申请号:PCT/IB2022/053323
申请日:2022-04-08
IPC分类号: A61K31/40 , A61K31/4162 , A61K31/495 , A61K31/496 , A61K31/506 , A61K31/519 , A61P25/00 , A61P25/28 , A61K31/403 , A61K31/4164 , A61K31/4985 , A61K31/522 , A61K31/69
摘要: Composition for use in the prevention and/or in the treatment of intellectual disability and neurodegenerative diseases in a subject with Down syndrome, wherein the composition comprises as an active agent at least one compound belonging to the class of dipeptidyl-peptidase IV (DPP4) enzyme inhibitors and also to the class of gliptins.